Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2009
12/30/2009WO2009120762A3 Human cardiovascular progenitor cells
12/30/2009WO2009120357A3 De novo anembryonic trophoblast vesicles and methods of making and using them
12/30/2009WO2009120043A3 Use for cd45+ cells or a cd45+ cell culture fluid for promoting the growth of mesenchymal stem cells
12/30/2009WO2009117553A3 Enhancing vessel lesion homing and repair potential of stem cells
12/30/2009WO2009117439A3 Combined chemical and genetic approaches for generation of induced pluripotent stem cells
12/30/2009WO2009116840A3 Chemical reagents regulating stem cell fate
12/30/2009WO2009114547A3 Enhanced dendritic cells for cancer immunotherapy
12/30/2009WO2009111755A3 Compensating for atrioventricular block using a nucleic acid encoding a sodium channel or gap junction protein
12/30/2009WO2009108654A3 Differential pressure pump system
12/30/2009WO2009100445A3 Compositions and methods which modulate g-protein signaling for the treatment of asthma
12/30/2009WO2009079456A3 Gender-specific separation of sperm cells and embryos
12/30/2009WO2009073523A3 De-differentiation of human cells
12/30/2009WO2009072142A3 Jathropha curcas hybrid nandan-2 for high oil content and construction of molecular markers specific to it
12/30/2009WO2009065093A3 Use of stem cells for wound healing
12/30/2009WO2009064917A3 Generation of an hla-negative osteogenic precursor cell line
12/30/2009WO2009059032A3 Uses and isolation of very small embryonic-like (vsel) stem cells
12/30/2009WO2009040666A3 Treatment of graft-versus-host disease
12/30/2009WO2009008950A3 Identification of trpml3 (mcoln3) as a salty taste receptor and use in assays for identifying taste (salty) modulators and/or therapeutics that modulate sodium transport, absorption or excretion and/or aldosterone and/or vasopressin production or release
12/30/2009WO2008119027A3 Genetic testing of telomere-associated genes in dyskeratosis congenita and related disorders
12/30/2009WO2008101100A3 Composition for stimulating formation of vascular structures
12/30/2009WO2008091908A3 Human cancer stem cells
12/30/2009WO2008086228A3 Arrays and methods for guided cell patterning
12/30/2009EP2138583A1 Position-independent and tissue specific expression of a transgene in milk of transgenic animals
12/30/2009EP2138580A1 Vector for gene therapy
12/30/2009EP2138577A1 Probe for visualizing cell cycle
12/30/2009EP2138576A1 Anti-claudin-4 antibody
12/30/2009EP2138572A1 Mesoangioblast-like cell as well as methods and uses relating thereto
12/30/2009EP2138571A1 Process for the preparation of multicellular spheroids
12/30/2009EP2138510A1 Methods of generating antibodies against cytokines
12/30/2009EP2138196A1 Methods to maintain, improve and restore the cartilage phenotype of chondrocytes
12/30/2009EP2138181A1 Method of preparing decellularized soft tissue, graft and culture material
12/30/2009EP2138179A1 Use of cytidine derivatives for the treatment of leukaemia
12/30/2009EP2138033A1 Controlling starch synthesis
12/30/2009EP2137536A1 Methods and compositions for inducing apoptosis by stimulating er stress
12/30/2009EP2137312A1 Manipulation of plant senescence using modified promoters
12/30/2009EP2137300A1 Pluripotent autologous stem cells from oral mucosa and methods of use
12/30/2009EP2137299A2 Micromechanical devices for control of cell-cell interaction, and methods of use thereof
12/30/2009EP2137298A1 Improved three-dimensional biocompatible skeleton structure containing nanoparticles
12/30/2009EP2137297A1 Methods for diagnosing biological samples containing stem cells
12/30/2009EP2137296A2 Somatic cell reprogramming
12/30/2009EP2137295A2 Composition and method for enabling proliferation of pluripotent stem cells
12/30/2009EP2136834A1 A non-destructive method to quantify and isolate antigen-specific b cells and uses thereof
12/30/2009EP2136823A1 Telencephalic glial-restricted cell populations and related compositions and methods
12/30/2009EP1509597B1 Method for isolating hair follicle mesenchymal stem cells
12/30/2009EP1470239B1 Psoriasin expression by breast epithelial cells
12/30/2009EP1438325B1 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods
12/30/2009EP1272663B1 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications
12/30/2009EP1117774B1 Method for generating diversity
12/30/2009EP1066394B1 Novel basal endosperm transfer cell layer (betl) specific genes
12/30/2009EP0804561B1 Regulated transcription of targeted genes and other biological events
12/30/2009EP0791058B1 Use of a nucleotide sequence encoding the enzyme i-scei
12/30/2009CN101617043A Nuclear reprogramming method
12/30/2009CN101613718A Genetically engineered duckweed
12/30/2009CN101613705A Optimizing glycan processing in plants
12/30/2009CN101613688A Von willebrand factor (vWF)-cleaving protease
12/30/2009CN101613678A Establishment of MDCK cell line stably expressing beta-galactoside alpha-2, 3-sialytransferase I(ST3GAL I)
12/30/2009CN101613673A Collection and culture method of enteromorpha linza spore
12/30/2009CN100575485C Targeted chromosomal mutagenesis using zinc finger nucleases
12/30/2009CN100575482C Novel cytokine zcytor17 ligand
12/30/2009CN100574612C Method for in vitro preservation of germ resource of chrysanthemum
12/30/2009CA2729375A1 Improved protein production and storage in plants
12/30/2009CA2729095A1 Antibody producing non-human mammals
12/30/2009CA2729074A1 Cellular differentiation process and its use for blood vessel build-up
12/30/2009CA2728804A1 Established human brown adipocyte line and method for differentiation from an hmads cell line
12/30/2009CA2728012A1 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life
12/30/2009CA2727053A1 Mesoangioblast-like cell as well as methods and uses relating thereto
12/30/2009CA2695590A1 Method of efficiently establishing induced pluripotent stem cells
12/29/2009US7638691 Plants and seeds of hybrid corn variety CH569011
12/29/2009US7638690 Plants and seeds of corn variety I285290
12/29/2009US7638689 Plants and seeds of corn variety I877879
12/29/2009US7638681 Auxin transport proteins
12/29/2009US7638620 Use to enhance apoptosis; antiproliferative agents
12/29/2009US7638619 Nucleotide sequences coding hepatocyte specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; immunotherapy; antitumor agents
12/29/2009US7638615 Fluorescent proteins and methods for using same
12/29/2009US7638607 Urocortin proteins and uses thereof
12/29/2009US7638605 Fully human antibodies directed against the human insulin-like growth factor-1 receptor
12/29/2009US7638602 Heterodimeric human cytokine receptor comprising Zcytor16/Zcytor11 components for use in treatment of cell proliferative, inflammatory and immune disorders
12/29/2009US7638601 Transient receptor potential channel TRPM8 and its use
12/29/2009US7638499 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
12/29/2009US7638498 Substances for preventing and treating autoimmune diseases
12/29/2009US7638497 For enhancing apoptosis and treating proliferative disorders; antitumor agents
12/29/2009US7638482 Protein kinase C zeta as a drug target for arthritis and other inflammatory diseases
12/29/2009US7638480 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease
12/29/2009US7638330 Method of promoting the differentiation of staminal cells
12/29/2009US7638329 In vitro method to generate dendritic Langerhans type cells
12/29/2009US7638328 Method for efficient transfer of human blastocyst-derived stem cells (hBS cells) from a feeder-supported to a feeder-free culture system, long-term propagation of hBS cells under feeder-free conditions and use of cultured hBS cells for applications in myocardial regeneration
12/29/2009US7638327 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with expression of B-cells and immunoglobulins); treatment of cancers, lymphomas, autoimmune diseases related to B-cells
12/29/2009US7638326 Activation and expansion of T-cells using an engineered multivalent signaling platform
12/29/2009US7638325 Microarray for activation and or stimulation of lymphocytes; immunotherapy; anticarcinogenic agents; viricides; bactericides; fungicides
12/29/2009US7638324 Useful in modulating apoptosis; diagnosis of prostate/ovarian cancer, and leukemia
12/29/2009US7638323 for treating or preventing hyperacute rejection; solid phase synthesis; genetic engineering
12/29/2009US7638311 using branching enzyme from a bacterium of the genus Neisseria; for use in pharmaceutical/cosmetic industries
12/29/2009US7638304 Hybrid fusion protein transcription regulator to induce interferon target gene expression
12/29/2009US7638303 Soluble ErbB3 receptor isoforms
12/29/2009US7638302 Soluble ErbB3 receptor isoforms
12/29/2009US7638301 Prodomain modulators of ADAM 10
12/29/2009US7638300 In vivo incorporation of unnatural amino acids
12/29/2009US7638298 Method for detecting mutation and a method for inducing mutation
12/29/2009US7638296 culturing in a medium containing insulin; use in the treatment of anemia; industrial scale production; high quality, purity
12/29/2009US7638289 Human T2R55 taste receptor and related assays for identifying human bitter taste modulators
1 ... 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 ... 1827